{{Rsnum
|rsid=4380275
|Chromosome=2
|position=773278
|Orientation=plus
|GMAF=0.2695
|Assembly=GRCh37.p10
|GenomeBuild=37.5
|dbSNPBuild=138
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 15.9 | 46.0 | 38.1
| HCB | 6.6 | 43.1 | 50.4
| JPT | 11.5 | 47.8 | 40.7
| YRI | 0.0 | 15.6 | 84.4
| ASW | 0.0 | 26.3 | 73.7
| CHB | 6.6 | 43.1 | 50.4
| CHD | 11.0 | 39.4 | 49.5
| GIH | 4.0 | 32.7 | 63.4
| LWK | 0.9 | 11.9 | 87.2
| MEX | 5.2 | 43.1 | 51.7
| MKK | 0.6 | 19.2 | 80.1
| TSI | 15.7 | 52.9 | 31.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=5E-6
  |OR=3.60
  |ORtxt=[2.041-6.365]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}